Repurposing Semaglutide for the Treatment of Cocaine Use Disorder — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Repurposing Semaglutide for the Treatment of Cocaine Use Disorder — Stella

Home/Cocaine Use Disorder/

View on ClinicalTrials.gov

Recruiting

Back to Cocaine Use Disorder trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

The University of Texas Health Science Center at Houston, Houston, Texas

Key details

Phase

Safety & dosing

Sponsor

The University of Texas Health Science Center, Houston

Collaborators

National Institute on Drug Abuse (NIDA)

Enrollment target

~75 participants

Started

January 2026

Primary completion

January 2029

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

18 Years and older

Last updated March 2026